Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The role of donor-derived exosomes in lung allograft rejection.

Ravichandran R, Bansal S, Rahman M, Sharma M, Liu W, Bharat A, Hachem R, Omar A, Smith MA, Mohanakumar T.

Hum Immunol. 2019 Mar 18. pii: S0198-8859(19)30140-5. doi: 10.1016/j.humimm.2019.03.012. [Epub ahead of print] Review.

PMID:
30898684
2.

Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations.

Tiriveedhi V, Gautam B, Sarma NJ, Askar M, Budev M, Aloush A, Hachem R, Trulock E, Myers B, Patterson AG, Mohanakumar T.

J Heart Lung Transplant. 2013 Aug;32(8):807-14. doi: 10.1016/j.healun.2013.06.003.

3.

Donor-Derived Exosomes With Lung Self-Antigens in Human Lung Allograft Rejection.

Gunasekaran M, Xu Z, Nayak DK, Sharma M, Hachem R, Walia R, Bremner RM, Smith MA, Mohanakumar T.

Am J Transplant. 2017 Feb;17(2):474-484. doi: 10.1111/ajt.13915. Epub 2016 Jul 16.

4.

Role of alloimmunity and autoimmunity in allograft rejection.

Banan B, Xu Z, Gunasekaran M, Mohanakumar T.

Clin Transpl. 2013:325-32.

5.

Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.

Angaswamy N, Tiriveedhi V, Sarma NJ, Subramanian V, Klein C, Wellen J, Shenoy S, Chapman WC, Mohanakumar T.

Hum Immunol. 2013 Nov;74(11):1478-85. doi: 10.1016/j.humimm.2013.07.002. Epub 2013 Jul 19. Review.

6.

A novel mechanism for immune regulation after human lung transplantation.

Mohanakumar T, Sharma M, Bansal S, Ravichandran R, Smith MA, Bremner RM.

J Thorac Cardiovasc Surg. 2019 May;157(5):2096-2106. doi: 10.1016/j.jtcvs.2018.12.105. Epub 2019 Feb 12.

PMID:
31288367
7.

Tissue-associated self-antigens containing exosomes: Role in allograft rejection.

Sharma M, Ravichandran R, Bansal S, Bremner RM, Smith MA, Mohanakumar T.

Hum Immunol. 2018 Sep;79(9):653-658. doi: 10.1016/j.humimm.2018.06.005. Epub 2018 Jun 15.

PMID:
29908844
8.

Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts.

Saini D, Weber J, Ramachandran S, Phelan D, Tiriveedhi V, Liu M, Steward N, Aloush A, Hachem R, Trulock E, Meyers B, Patterson GA, Mohanakumar T.

J Heart Lung Transplant. 2011 Jun;30(6):624-31. doi: 10.1016/j.healun.2011.01.708. Epub 2011 Mar 16.

9.

Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft Rejection.

Bharat A, Mohanakumar T.

J Immunol Res. 2017;2017:6312514. doi: 10.1155/2017/6312514. Epub 2017 Jan 9. Review.

10.

Antihuman leukocyte antigen antibody-induced autoimmunity: role in chronic rejection.

Nath DS, Basha HI, Mohanakumar T.

Curr Opin Organ Transplant. 2010 Feb;15(1):16-20. doi: 10.1097/MOT.0b013e3283342780. Review.

11.

The role of exosomes in allograft immunity.

Bansal S, Sharma M, R R, Mohanakumar T.

Cell Immunol. 2018 Sep;331:85-92. doi: 10.1016/j.cellimm.2018.06.003. Epub 2018 Jun 7. Review.

PMID:
29907298
12.

Zbtb7a induction in alveolar macrophages is implicated in anti-HLA-mediated lung allograft rejection.

Nayak DK, Zhou F, Xu M, Huang J, Tsuji M, Yu J, Hachem R, Gelman AE, Bremner RM, Smith MA, Mohanakumar T.

Sci Transl Med. 2017 Jul 12;9(398). pii: eaal1243. doi: 10.1126/scitranslmed.aal1243.

13.

ABO incompatible renal transplants and decreased likelihood for developing immune responses to HLA and kidney self-antigens.

Subramanian V, Gunasekaran M, Gaut JP, Phelan D, Vachharajani N, Santos RD, Wellen J, Shenoy S, Mohanakumar T.

Hum Immunol. 2016 Jan;77(1):76-83. doi: 10.1016/j.humimm.2015.10.014. Epub 2015 Oct 22.

PMID:
26476207
14.

Prevalence of antibodies to lung self-antigens (Kα1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: Single center experience.

Rao U, Sharma M, Mohanakumar T, Ahn C, Gao A, Kaza V.

Transpl Immunol. 2019 Jun;54:65-72. doi: 10.1016/j.trim.2019.02.006. Epub 2019 Feb 20.

PMID:
30794945
15.

Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients.

Golocheikine A, Nath DS, Basha HI, Saini D, Phelan D, Aloush A, Trulock EP, Hachem RR, Patterson GA, Ahearn JM, Mohanakumar T.

J Heart Lung Transplant. 2010 Apr;29(4):410-6. doi: 10.1016/j.healun.2009.10.003.

16.

The Presence of Pretransplant HLA Antibodies Does Not Impact the Development of Chronic Lung Allograft Dysfunction or CLAD-Related Death.

Zazueta OE, Preston SE, Moniodis A, Fried S, Kim M, Townsend K, Wood I, Boukedes S, Guleria I, Camp P, El-Chemaly S, Rosas IO, Chandraker A, Milford E, Goldberg HJ.

Transplantation. 2017 Sep;101(9):2207-2212. doi: 10.1097/TP.0000000000001494.

PMID:
27893614
17.

De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.

Tikkanen JM, Singer LG, Kim SJ, Li Y, Binnie M, Chaparro C, Chow CW, Martinu T, Azad S, Keshavjee S, Tinckam K.

Am J Respir Crit Care Med. 2016 Sep 1;194(5):596-606. doi: 10.1164/rccm.201509-1857OC.

PMID:
26967790
18.
19.

Long-Term Persistence of Donor Alveolar Macrophages in Human Lung Transplant Recipients That Influences Donor-Specific Immune Responses.

Nayak DK, Zhou F, Xu M, Huang J, Tsuji M, Hachem R, Mohanakumar T.

Am J Transplant. 2016 Aug;16(8):2300-11. doi: 10.1111/ajt.13819. Epub 2016 May 23.

20.

Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection.

Takenaka M, Subramanian V, Tiriveedhi V, Phelan D, Hachem R, Trulock E, Gelman AE, Patterson GA, Hoshinaga K, Mohanakumar T.

J Heart Lung Transplant. 2012 Nov;31(11):1214-22. doi: 10.1016/j.healun.2012.08.011. Epub 2012 Sep 11.

Supplemental Content

Support Center